Cite
HARVARD Citation
Bogenberger, J. et al. (n.d.). Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies. Leukemia & lymphoma. 56 (1), pp. 226-229. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bogenberger, J. et al. (n.d.). Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies. Leukemia & lymphoma. 56 (1), pp. 226-229. [Online].